Security key
P8696W104
SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA)
CUSIP: P8696W104
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / Common Shares, par value US$0.001 per share
- Total 13F shares
- 13,494,548
- Total 13F value
- $79,577,415
- Share change
- -163,813
- SEC-reported price per share
- $6.47
- Number of holders
- 10
- Value change
- -$1,059,870
- Number of buys
- 1
- Number of sells
- 4
- Shares outstanding
- 71,872,133
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2024
Institutions
10
Top holders
10
SVA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2024
Previous quarter: Q1 2024
SINOVAC BIOTECH LTD SEC filings
SINOVAC BIOTECH LTD company facts
Broader feeds
Reporting periods
Holder history for CUSIP P8696W104
Recent filing periods:
Ownership snapshot
Top reported holders of SVA - SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Vivo Capital, LLC
Disclosed value leader
ORBIMED ADVISORS LLC
Comparable rows
14/14
Latest evidence
31 Mar 2024
13F
Lead comparable stake: 16%
Showing 1-6 of 14 holder rows.
Quick read
Vivo Capital, LLC leads the comparable SEC ownership view at 16%.
14 of 14 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Vivo Capital, LLC's linked filing trail.
Comparable ownership
Top 5
Vivo Capital, LLC
16%
ORBIMED ADVISORS LLC
3.8%
RENAISSANCE TECHNOLOGIES LLC
1.8%
Neumann Advisory Hong Kong Ltd
0.44%
STATE STREET CORP
0.22%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 14 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Vivo Capital, LLC |
13F
Company
|
16%
|
$76,346,000
11,800,000 shares
|
— | 31 Mar 2024 |
| ORBIMED ADVISORS LLC |
13F
Company
|
3.8%
|
$340,000,000
2,718,735 shares
|
— | 31 Mar 2024 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
1.8%
|
$849,000
1,312,520 shares
|
— | 31 Mar 2024 |
| Neumann Advisory Hong Kong Ltd |
13F
Company
|
0.44%
|
$2,042,000
315,586 shares
|
— | 31 Mar 2024 |
| STATE STREET CORP |
13F
Company
|
0.22%
|
$1,040,861
160,875 shares
|
— | 31 Mar 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.04%
|
$179,328
27,717 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
10
Shares
13,494,548
Rows available
10
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
11
Q2 2024 holders
10
Holder diff
-1
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend